ARTERIVAC

Inactivated vaccine adjuvanted with aluminum hydroxide for the prevention of viral arteritis

equin

Inactivated equine viral arteritis virus: minimum 108

DECP50/ml before

Pharmaceutical form:

Suspension for injection.

Indications:

Prevention by active immunization of equines against

equine viral arteritis.

Administration:

Intramuscular route.

Vacation dose: 2 ml.